Aprepitant Capsule
Product Images NDC 51407-703

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Aprepitant (NDC 51407-703). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-701-05cb (Aprepitant 40mg mockup.jpg)

Packaging label for Aprepitant Capsules, USP 40 mg oral capsules. The label indicates the package contains 5 capsules and states it is a bulk package not intended for dispensing. Manufactured by Pharmathen International S.A., Greece, and marketed by GSMS, Incorporated, Camarillo, CA. The label includes Rx only and NDC 51407-701-05.*

FDA Label Image

51407-702-06cb (Aprepitant 80mg mockup.jpg)

Aprepitant Capsules, USP 80 mg oral capsules packaging label. The carton indicates each capsule contains 80 mg of aprepitant and includes 6 capsules. It is labeled for adults and pediatric patients 12 years and older. The product is manufactured by Pharmathen International S.A., Greece, and marketed by GSMS Incorporated, Camarillo, CA. The packaging is marked as Rx only and is a bulk package not intended for dispensing.*

FDA Label Image

51407-703-06cb (Aprepitant 125mg mockup.jpg)

The image shows the packaging label for Aprepitant Capsules, USP 125 mg. The label displays the product name prominently with the strength in a purple bar. It states each capsule contains 125 mg of aprepitant and includes warnings about the package not being child-resistant and that it is a bulk package. The label is for a 6-capsule package manufactured by Pharmathen International S.A. in Greece and marketed by GSMS, Incorporated, USA. The NDC code 51407-703-06 appears on the label, along with storage instructions and barcode placement.*

FDA Label Image

51407-704-03cb (Aprepitant 125g 80mg mockup.jpg)

Box label for Aprepitant Capsules, USP 125 mg and 80 mg oral capsules. The label indicates a 3-day pack containing one 125 mg capsule and two 80 mg capsules. Labeler is Golden State Medical Supply, Inc., with manufacturer Pharmathen International S.A., Greece. The label includes dosage instructions, storage conditions, and capsule images in pink (125 mg) and gray (80 mg).*

FDA Label Image

Structural Formula (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 01)

Chemical structure diagram of aprepitant, illustrating its molecular framework with labeled atoms and functional groups.*

FDA Label Image

Figure 1 (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 02)

Two line graphs titled Study 1 and Study 2 compare the percent of patients over time (hours) for Aprepitant Regimen versus Standard Therapy. Each graph shows patient survival or response rates with Aprepitant Regimen maintaining a higher percentage of patients compared to Standard Therapy up to 120 hours. Sample sizes for each treatment group are indicated.*

FDA Label Image

Figure 2 (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 03)

Two bar graphs labeled Study 1 and Study 2 showing the percentage of patients across chemotherapy cycles 2 to 6. Each graph compares patients on the Aprepitant Regimen versus Standard Therapy. The y-axis represents the percent of patients, and the x-axis indicates chemotherapy cycles. Patient counts for each group and cycle are listed below each graph.*

FDA Label Image

Figure 3 (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 04)

A survival curve graph comparing the percent of patients over time (up to 48 hours) for Aprepitant 40 mg versus Ondansetron. The graph shows a higher percentage of patients maintained on Aprepitant 40 mg compared to Ondansetron throughout the time course. The x-axis is labeled Hours and the y-axis is labeled Percent of Patients.*

FDA Label Image

Torrent Logo (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 05)

FDA Label Image

Logo (B98c7956 Cd1b 476f Be29 Abec7d42aeb1 06)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.